Official websites use .gov
A
.gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A
lock (
) or https:// means you’ve safely connected to
the .gov website. Share sensitive information only on official,
secure websites.
This report discusses the relationship between TB and sustainable development, and advocates for increased dialogue and action among TB partners.
The Strategic Plan is the result of an independent and collaborative effort by institutions, agencies, and individuals representing the full spectrum of TB care, control, and prevention efforts. The Strategic Plan is intended to encourage a comprehensive, coordinated, and sustained TB training and education effort that is targeted to the specific needs of various providers and communities. It establishes priorities and directions for TB training and education efforts for the five-year period from 2004 to 2008.
This bilingual publication puts a human face on the TB epidemic and depicts the suffering of people affected by this disease through images and interviews. The publication also describes the efficacy of the DOTS program in fighting TB.
This book describes exposure, infection, disease, and death from TB using epidemiological data. It reviews statistics, including the number of TB cases, the duration of infection in these cases, and the number of case contact interactions per unit of time.
This book presents five papers that were used as background to a workshop on "Improving TB Drug Management: Accelerating DOTS Expansion" on June 2002, in Washington, DC. The papers address the weaknesses in drug management programs of certain countries and provide a framework for strengthening these programs through country-specific action plans.
This guideline promotes collaboration between TB and HIV/AIDS programs to reduce the burden for people affected by both diseases.
This report assesses the effectiveness, cost, and cost-effectiveness of the public-private mix DOTS (PPM-DOTS) program in pilot projects in Hyderabad and Delhi, India.
This report discusses compounds with potential for the treatment of TB and categorizes them into the discovery, preclinical, or clinical phases of development.
This guideline sets forth the framework to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. The framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programs.
This group of four fact sheets explain the origin and purpose of the Global Drug Facility (GDF), how the GDF works, how to apply to the GDF for a grant of TB drugs, and how to buy drugs through the GDF.
